Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

HOPE MCLEAN

Allopathic & Osteopathic Physicians Obstetrics & Gynecology

NPI
1477756468
CMS profile
111868
Location
MOBILE, AL

General Payments · PY2018–2024

$2,402.66

  • Reported across 125 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$261.98

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $248.63 12
Education $13.35 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
MAYNE PHARMA COMMERCIAL LLC $102.39 4
Exeltis, USA Inc. $44.82 2
MILLICENT US INC $33.11 2
ABBVIE INC. $25.57 1
Novo Nordisk AS $14.94 1
Sumitomo Pharma America, Inc. $13.98 1
Sage Therapeutics, Inc. $13.67 1
SHIELD THERAPEUTICS INC $13.50 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $272.70 13
PY2019 $306.49 14
PY2020 $186.50 11
PY2021 $607.89 29
PY2022 $452.81 27
PY2023 $314.29 18
PY2024 $261.98 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $25.57 05/29/2024 Food and Beverage Undisputed 01/23/2026 1105007441 CMS
Exeltis, USA Inc. $19.48 02/06/2024 Food and Beverage Undisputed 01/23/2026 1149999288 CMS
Exeltis, USA Inc. $25.34 05/21/2024 Food and Beverage Undisputed 01/23/2026 1149999290 CMS
MAYNE PHARMA COMMERCIAL LLC $34.08 01/23/2024 Food and Beverage Undisputed 01/23/2026 1154713615 CMS
MAYNE PHARMA COMMERCIAL LLC $16.75 07/25/2024 Food and Beverage Undisputed 01/23/2026 1154713619 CMS
MAYNE PHARMA COMMERCIAL LLC $19.46 09/24/2024 Food and Beverage Undisputed 01/23/2026 1154713621 CMS
MAYNE PHARMA COMMERCIAL LLC $32.10 12/04/2024 Food and Beverage Undisputed 01/23/2026 1154713617 CMS
MILLICENT US INC $13.35 05/20/2024 Education Undisputed 01/23/2026 1150909813 CMS
MILLICENT US INC $19.76 05/20/2024 Food and Beverage Undisputed 01/23/2026 1150909815 CMS
Novo Nordisk Inc $14.94 02/27/2024 Food and Beverage Undisputed 01/23/2026 1097010700 CMS
Sage Therapeutics, Inc. $13.67 10/10/2024 Food and Beverage Undisputed 01/23/2026 1120398305 CMS
SHIELD THERAPEUTICS INC $13.50 01/12/2024 Food and Beverage Undisputed 01/23/2026 1150116561 CMS
Sumitomo Pharma America, Inc. $13.98 06/24/2024 Food and Beverage Undisputed 01/23/2026 1148889003 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.